Phosphatidylinositol Glycan Anchor Biosynthesis, class G (PIGG) is an ethanolamine phosphate transferase catalyzing the modification of glycosylphosphatidylinositol (GPI). GPI serves as an anchor on the cell membrane for surface proteins called GPI-anchored proteins (GPI-APs). Pathogenic variants in genes involved in the biosynthesis of GPI cause inherited GPI deficiency (IGD), which still needs to be further characterized.
We describe 22 individuals from 19 unrelated families with biallelic variants in PIGG. We analyzed GPI-AP surface levels on granulocytes and fibroblasts for three and two individuals, respectively. We demonstrated enzymatic activity defects for PIGG variants in vitro in a PIGG/PIGO double knockout system.
Phenotypic analysis of reported individuals reveals shared PIGG deficiency–associated features. All tested GPI-APs were unchanged on granulocytes whereas CD73 level in fibroblasts was decreased. In addition to classic IGD symptoms such as hypotonia, intellectual disability/developmental delay (ID/DD), and seizures, individuals with PIGG variants of null or severely decreased activity showed cerebellar atrophy, various neurological manifestations, and mitochondrial dysfunction, a feature increasingly recognized in IGDs. Individuals with mildly decreased activity showed autism spectrum disorder.
This in vitro system is a useful method to validate the pathogenicity of variants in PIGG and to study PIGG physiological functions.
Subscribe to Journal
Get full journal access for 1 year
only $33.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Data availability statement
Data and materials developed in support of the paper are available upon request.
Zhao, J. J. et al. Reduced cell surface levels of GPI-linked markers in a new case with PIGG loss of function. Hum. Mutat. 38, 1394–1401 (2017).
Murakami, Y. et al. Mutations in PIGB cause an inherited GPI biosynthesis defect with an axonal neuropathy and metabolic abnormality in severe cases. Am. J. Hum. Genet. 105, 384–394 (2019).
Makrythanasis, P. et al. Pathogenic variants in PIGG cause intellectual disability with seizures and hypotonia. Am. J. Hum. Genet. 98, 615–626 (2016).
Murakami, Y. et al. Mechanism for release of alkaline phosphatase caused by glycosylphosphatidylinositol deficiency in patients with hyperphosphatasia mental retardation syndrome. J. Biol. Chem. 287, 6318–6325 (2012).
Bellai-Dussault, K. et al. Clinical variability in inherited glycosylphosphatidylinositol deficiency disorders. Clin. Genet. 95, 112–121 (2019).
Kinoshita, T. Biosynthesis and biology of mammalian GPI-anchored proteins. Open Biol. 10, 190290 (2020).
Bayat, A. et al. Lessons learned from 40 novel PIGA patients and a review of the literature. Epilepsia. 61, 1142–1155 (2020).
Lionel, A. C. et al. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet. Med. 20, 435–443 (2018).
Wright, C. F. et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet. 385, 1305–1314 (2015).
Sobreira, N., Schiettecatte, F., Valle, D. & Hamosh, A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum. Mutat. 36, 928–930 (2015).
Kopanos, C. et al. VarSome: the human genomic variant search engine. Bioinformatics. 35, 1978–1980 (2019).
Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310–315 (2014).
UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 47, D506–D515. (2019).
Zhou, X. et al. Exploring genomic alteration in pediatric cancer using ProteinPaint. Nat. Genet. 48, 4–6 (2016).
Omasits, U., Ahrens, C. H., Müller, S. & Wollscheid, B. Protter: interactive protein feature visualization and integration with experimental proteomic data. Bioinformatics. 30, 884–886 (2014).
Lee, C. M. et al. UCSC Genome Browser enters 20th year. Nucleic Acids Res. 48, D756–D761 (2020).
Tanigawa, J. et al. Phenotype-genotype correlations of PIGO deficiency with variable phenotypes from infantile lethality to mild learning difficulties. Hum. Mutat. 38, 805–815 (2017).
Wu, C. et al. BioGPS: building your own mash-up of gene annotations and expression profiles. Nucleic Acids Res. 44, D313–6 (2016).
Su, A. I. et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. U.S.A. 101, 6062–6067 (2004).
Zhao, P. et al. Proteomic identification of glycosylphosphatidylinositol anchor-dependent membrane proteins elevated in breast carcinoma. J. Biol. Chem. 287, 25230–25240 (2012).
Tarailo-Graovac, M. et al. The genotypic and phenotypic spectrum of PIGA deficiency. Orphanet J. Rare Dis. 10, 23 (2015).
Nguyen, T. T. M. et al. Mutations in PIGS, encoding a GPI transamidase, cause a neurological syndrome ranging from fetal akinesia to epileptic encephalopathy. Am. J. Hum. Genet. 103, 602–611 (2018).
Nguyen, T. T. M. et al. Biallelic variants in the GPI transamidase subunit PIGK cause a neurodevelopmental syndrome with hypotonia, cerebellar atrophy, and epilepsy. Am. J. Hum. Genet. 106, 484–495 (2020).
Rodenburg, R. J. T. Biochemical diagnosis of mitochondrial disorders. J. Inherit. Metab. Dis. 34, 283–292 (2011).
van den Heuvel, L. P., Smeitink, J. A. & Rodenburg, R. J. T. Biochemical examination of fibroblasts in the diagnosis and research of oxidative phosphorylation (OXPHOS) defects. Mitochondrion 4, 395–401 (2004).
Thompson, M. D. et al. Hyperphosphatasia with neurologic deficit: a pyridoxine-responsive seizure disorder? Pediatr. Neurol. 34, 303–307 (2006).
Kuki, I. et al. Vitamin B6-responsive epilepsy due to inherited GPI deficiency. Neurology 81, 1467–1469 (2013).
This work is supported by Canadian Institutes of Health Research (CIHR) and Fonds de Recherche du Québec–Santé (FRQS) awards to P.M.C. We thank Keiko Kinoshita, Saori Umeshita, Kae Imanishi (Osaka University) for technical help. T.S.B. is supported by the Netherlands Organisation for Scientific Research (ZonMW Veni, grant 91617021), a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation, an Erasmus MC Fellowship 2017, and Erasmus MC Human Disease Model Award 2018. This work was supported by JSPS and MEXT KAKENHI grants (JP16H04753 and JP17H06422), and grants from AMED (20ek0109418h0002) and MHLW of Japan. Some families were collected as part of the SYNaPS Study Group collaboration funded by the Welcome Trust and strategic award (Synaptopathies) funding (WT093205 MA and WT104033AIA). This research was conducted as part of the Queen Square Genomics group at University College London, supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. Family 13 was identified in the CAUSES Study, funded by British Columbia Children’s Hospital Foundation and Genome BC.
Informed written consent was obtained for every participant either from themselves or their parents. Ethical approval was granted by Centre Hospitalier Universitaire Sainte-Justine Research Center and Sick Kids Hospital. Consent was received for the use of identifying patient photographs.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tremblay-Laganière, C., Maroofian, R., Nguyen, T.T.M. et al. PIGG variant pathogenicity assessment reveals characteristic features within 19 families. Genet Med (2021). https://doi.org/10.1038/s41436-021-01215-9